A nasal vaccine has been in development since June 2020 that promises to block any contamination from the Covid-19 virus. The French BioMAP research team from INRAE-University of Tours, developed the alternative project to the traditional vaccine and, last Thursday (20), announced the creation of a startup that will be responsible for the development and operation of the solution.
The most recent pre-clinical results allowed this new step, despite having been done with the Delta variant over the winter. However, the findings point to the vaccine’s robustness.
The French startup LoValtech thus saw the light of day and holds the exclusive license for the worldwide exploitation of the patent on the vaccine, granted by the University of Tours and INRAE. It will be the new company that will conduct the tests in humans, necessary for the authorization of the commercialization of the vaccine at the end of August 2023, or even the beginning of 2024. The vaccine must be produced by the company Bioways, based in Toulouse, France.
According to a statement from INRAE and the University of Tours, the added value of this vaccine lies in its ability to cut transmission between individuals, acting directly on the nasal mucosa. In the laboratory, preclinical tests demonstrated the vaccine’s effectiveness after two nasal immunizations spaced three weeks apart.
know more
+ SP: Man dies standing, leaning against car, and scene scares residents on the coast
+ One twin became vegan, the other ate meat. Check the result
+ Reincarnation in history: an age-old belief
+ Andressa Urach asks for money on the internet: ‘Help me pay my card bill’
+ Horoscope: check today’s forecast for your sign
+ CNH: see what you need to know for the application and renewal
+ See which were the most stolen cars in SP in 2021
+ Expedition identifies giant squid responsible for ship sinking in 2011
+ Everything you need to know before buying a crockpot
+ US Agency warns: never wash raw chicken meat
+ What is known about fluorone?
+ Trick to squeeze lemons becomes a craze on social media
+ IPVA 2022 SP: see how to consult and pay the tax
#Covid19 #nasal #vaccine #start #tested #humans